The composition of metabolic products depends not only on external factors, but also, to a significant extent, on natural variations in the genome. In an international study, German scientists have identified previously unknown variations in genes that, in some cases, drastically influence the concentration of small molecules in the blood. These regulators cause a metabolic enzyme to be more or less active, or a transport protein to be more or less efficient, thereby resulting in higher or lower concentrations of metabolic products.
The team led by Claudia Langenberg at Charité Berlin investigated the effect of gene variants on 174 different metabolites in 85,000 people: “In doing so, we found a surprising number of correlations between certain gene variants and changes in the concentration of small molecules in the blood,” she reports. For example, high levels of the amino acid serine in the blood appear to protect against a rare eye condition, macular telangiectasia, which opens up new therapeutic options. They have also identified a new mechanism that explains how impaired signal transduction via a receptor (GLP2R) increases the risk of developing type 2 diabetes.
“A distinctive feature of our study is the extreme effects we have observed and their potential relevance to medical research. We were able to identify gene variants whose influence on metabolism is a good three times stronger than the previously known effects of more common genetic variations, for example on body mass index,” explains Langenberg, who is making her data available to researchers worldwide via an interactive website.
Reference:
BIH, Charité Berlin; Cambridge University; Melbourne University; Helmholtz Zentrum München; ICL London
A cross-platform approach identifies genetic regulators of human metabolism and health, Nature Genetics 2021, https://www.nature.com/articles/s41588-020-00751-5